Cannabis Outfit Recruits Israeli Nobel Laureate for Board
Cannabis-based pharma company Panaxia, which is set to merge with Tel Aviv-listed shelf company Herodium, announced Israeli biologist Aaron Ciechanover will join its board
For daily updates, subscribe to our newsletter by clicking here.
Ciechanover, 72, won a Nobel prize in chemistry in 2004 together with Israeli biochemist Avram Hershko for their work on characterizing the method that cells employ a regulatory protein called ubiquitin to breakdown and recycle proteins.
Panaxia develops cannabis-based pharmaceuticals. The company also manufactures 9 of out of the 10 medical cannabis brands available in Israel today and holds a local distributor license.
Ciechanover was initially hesitant to join a commercial venture, the researcher told Calcalist in an interview, but conversations with the Panaxia’s management led him to believe they would be open to his scientific input.